webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

DC-1

  CAS No.:   Cat No.: BADC-00335   Purity: ≥95% 4.5  

DC-1 is a potent ADC cytotoxin payload that causes DNA damage leading to apoptosis in malignant cells. Its role in antibody-drug conjugates enhances targeted delivery of cytotoxic agents, improving treatment specificity and efficacy.

DC-1

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Cytotoxin
Molecular Formula
C31H24ClN5O3
Molecular Weight
550.01
Shipping
Room temperature, or blue ice upon request.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
5 mg $1099 In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(S)-5-amino-N-(2-(1-(chloromethyl)-5-hydroxy-2,3-dihydro-1H-benzo[e]indole-3-carbonyl)-1H-indol-5-yl)-1H-indole-2-carboxamide;
Appearance
Soild powder
Shipping
Room temperature, or blue ice upon request.
NCT NumberCondition Or DiseasePhaseStart DateSponsorStatus
NCT02336984Breast CancerPhase 1, Phase 22021-01-11H. Lee Moffitt Cancer Center and Research InstituteWithdrawn (PI left Abramson Cancer Center and study never opened at Moffitt Cancer Center.)
NCT01813383Celiac Disease Patients Following Recommendations of ESPGHAN2013-03-19Corporacion Parc TauliCompleted
NCT02787915Renal Cell CarcinomaPhase 12016-06-02Xuzhou Medical UniversityUnknown Verified May 2016 by Junnian Zheng, Xuzhou Medical University. Recruitment status was Not yet recruiting
NCT02061332Breast CancerPhase 1, Phase 22020-04-10Abramson Cancer Center of the University of PennsylvaniaCompleted
NCT03630809Breast CancerPhase 22021-11-22H. Lee Moffitt Cancer Center and Research InstituteSuspended (Suspended for protocol revisions)
1. Performance of digital morphology analyzer CellaVision DC-1
Minjeong Nam, Mina Hur, Hanah Kim, Gun-Hyuk Lee, Sumi Yoon Clin Chem Lab Med . 2022 Oct 31;61(1):133-141. doi: 10.1515/cclm-2022-0829.
Objectives:CellaVision DC-1 (DC-1, Sysmex, Kobe, Japan) is a newly launched digital morphology analyzer that was developed mainly for small to medium-volume laboratories. We evaluated the precision, qualitative performance, comparison of cell counts between DC-1 and manual counting, and turnaround time (TAT) of DC-1.Methods:Using five peripheral blood smear (PBS) slides spanning normal white blood cell (WBC) range, precision and qualitative performance of DC-1 were evaluated according to the Clinical and Laboratory Standards Institute (CLSI) EP15-A3, EP15-Ed3-IG1, and EP12-A2 guidelines. Cell counts of DC-1 and manual counting were compared according to the CLSI EP 09C-ED3 guidelines, and TAT of DC-1 was also compared with TAT of manual counting.Results:DC-1 showed excellent precision (%CV, 0.0-3.5%), high specificity (98.9-100.0%), and high negative predictive value (98.4-100.0%) in 18 cell classes (12 WBC classes and six non-WBC classes). However, DC-1 showed 0% of positive predictive value in seven cell classes (metamyelocytes, myelocytes, promyelocytes, blasts, plasma cells, nucleated red blood cells, and unidentified). The largest absolute mean differences (%) of DC-1 vs. manual counting was 2.74. Total TAT (min:s) was comparable between DC-1 (8:55) and manual counting (8:55).Conclusions:This is the first study that comprehensively evaluated the performance of DC-1 including its TAT. DC-1 has a reliable performance that can be used in small to medium-volume laboratories for assisting PBS review. However, DC-1 may make unnecessary workload for cell verification in some cell classes.
2. Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens
R Tosi, S Ferrone, O Segatto, G Corte, P G Natali Immunogenetics . 1984;19(2):109-16. doi: 10.1007/BF00387853.
The tissue distribution and the ontogeny of DC-1 antigens have been investigated and compared with those of HLA-DR antigens. Indirect immunofluorescence (IIF) staining of surgically removed normal tissues from adults with the monoclonal antibody (MoAb) BT3.4 has detected DC-1 antigens in tissues of various embryologic origin. The tissue distribution of DC-1 antigens is more restricted than that of HLA-DR antigens, as the former are not detected in duodenal epithelium, colon mucosa, and ductal mammary gland epithelium. In fetuses up to 26 weeks of age, DC-1 antigens were detected only on cortical and medullary thymic dendritic cells with an anatomic distribution similar to that of reticuloepithelial cells and in endothelial cells of the small intestine. At this stage of intrauterine life, HLA-DR antigens have already reached their full tissue distribution. The tissue distribution and the ontogeny of DC-1 antigens resemble those of their murine counterparts, i.e., the I-A antigens.
3. CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer
Yu Deng, Man Zhang, Xin-Dong Liu, Fang-Fang Liu, Peng Wang, Ya-Qi Duan, Yu-Ting Dong, Rui Huang, Bo Zhong, Peng Zhang, Qian Chu, Wei Yang, Dandan Lin Nat Commun . 2020 Nov 30;11(1):6119. doi: 10.1038/s41467-020-19973-6.
The efficacy of checkpoint immunotherapy to non-small cell lung cancer (NSCLC) largely depends on the tumor microenvironment (TME). Here, we demonstrate that CCL7 facilitates anti-PD-1 therapy for the KrasLSL-G12D/+Tp53fl/fl(KP) and the KrasLSL-G12D/+Lkb1fl/fl(KL) NSCLC mouse models by recruiting conventional DC 1 (cDC1) into the TME to promote T cell expansion. CCL7 exhibits high expression in NSCLC tumor tissues and is positively correlated with the infiltration of cDC1 in the TME and the overall survival of NSCLC patients. CCL7 deficiency impairs the infiltration of cDC1 in the TME and the subsequent expansion of CD8+and CD4+T cells in bronchial draining lymph nodes and TME, thereby promoting tumor development in the KP mouse model. Administration of CCL7 into lungs alone or in combination with anti-PD-1 significantly inhibits tumor development and prolongs the survival of KP and KL mice. These findings suggest that CCL7 potentially serves as a biomarker and adjuvant for checkpoint immunotherapy of NSCLC.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Payload Development Biological Payload Chemical Payload Protein Toxin Nanocarrier Microtubule Inhibitors DNA Damaging Agents RNA Polymerase Inhibitors Protein Degraders

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Maytansine and Its Analogues Cytotoxic Agents Used in Antibody–Drug Conjugates Exatecan Mesylate in ADCs: A New Topo I Inhibitor What is Calicheamicin? What is Monomethyl Auristatin E (MMAE)? What is Monomethyl Auristatin F (MMAF)? What is Pyrrolobenzodiazepine (PBD)? Antiviral Potential of Thapsigargin in COVID-19 Research ADC Payloads Explained: Current Types and Cutting-Edge Research Progress Tubulin Inhibitors - Highly Potential ADC Payloads

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Amino-PEG6-propionic acid | Methyltetrazine-amido-N-bis(PEG4-acid) | Boc-aminooxy-ethyl-SS-propanol | SC209 intermediate-1 | Bocaminooxyacetamide-PEG3-alkyne | Boc-Aminooxy-PEG2-bromide | Macropa-NCS | Indole-C2-amide-C2-NH2 | Aminooxy-PEG2-BCN | Aminooxy-PEG4-alcohol | DC-1
Send Inquiry
Verification code
Inquiry Basket